AUTUMN ASKINS: Open Payments
NPI 1972176378 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 13 payments from 4 companies in 2025. Trend: 2023 $208 · 2024 $196 · 2025 $373
Food & beverage: $274Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $149 |
| Regeneron Healthcare Solutions, Inc. | 2 | $114 |
| GENZYME CORPORATION | 3 | $56 |
| Optinose US, Inc. | 2 | $54 |
Products named: NUCALA, DUPIXENT, Xhance.
Industry payments across PA — which companies pay providers there.
